Assuntos: DOENÇAS AUTOIMUNES, LÚPUS ERITEMATOSO SISTÊMICO, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GREIN, Ingrid Herta Rotstein et al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study. Lupus, v. 29, n. 8, p. 934-942, 2020Tradução . . Disponível em: https://doi.org/10.1177/0961203320928406. Acesso em: 30 set. 2024.APA
Grein, I. H. R., Pinto, N. F., Lobo, A., Groot, N., Sztajnbok, F., Silva, C. A. A. da, et al. (2020). Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study. Lupus, 29( 8), 934-942. doi:10.1177/0961203320928406NLM
Grein IHR, Pinto NF, Lobo A, Groot N, Sztajnbok F, Silva CAA da, Marques LBP, Appenzeller S, Islabao AG, Magalhaes CS. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study [Internet]. Lupus. 2020 ; 29( 8): 934-942.[citado 2024 set. 30 ] Available from: https://doi.org/10.1177/0961203320928406Vancouver
Grein IHR, Pinto NF, Lobo A, Groot N, Sztajnbok F, Silva CAA da, Marques LBP, Appenzeller S, Islabao AG, Magalhaes CS. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study [Internet]. Lupus. 2020 ; 29( 8): 934-942.[citado 2024 set. 30 ] Available from: https://doi.org/10.1177/0961203320928406
